Saturday, July 12, 2025

Latest

Biotech Firm IN8bio Eyes US$40 Million IPO

Clinical-stage biopharmaceutical company IN8bio, Inc. (Nasdaq: INAB) began trading on the Nasdaq Global Market today under the symbol “INAB”. The firm’s initial public offering is looking to raise US$40.0 million and is expected to close on August 3, 2021.

The offering consists of 4,000,000 common shares selling at US$10.00 per share. The company intends to use the proceeds of its offering on advancing the development of its two lead product candidates in T-cell therapies for treating cancer.

The company granted a 30-day over-allotment option to purchase additional 600,000 common shares at the same IPO price. B. Riley Securities, Inc. is acting as the sole bookrunner for the said offering.

The New York-based biotech company is focused on developing and commercializing gamma-delta T cells to treat cancer patients. The firm reported US$8.6 million net loss in 2020 and an approximately US$15 million cash balance as of March 31, 2021


Information for this briefing was found via Edgar and IN8bio. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Mergers Set the Stage for Uranium’s Growth Cycle | Forum-Baselode Merger

The Goal is Gold Production as Soon as Possible! | Gordon Robb – ESGOLD Corp.

Snowline Gold: The Multi Billion Dollar Valley PEA

Recommended

First Majestic Produces 7.9 Silver Equivalent Ounces In Q2, Lifts Production Guidance

Antimony Resources Drills 4.17% Antimony Over 7.4 Metres At Bald Hill

Related News

Tiger Williams-Led SPAC Williams Rowland Acquisition Seeks To Raise US$200 Million In IPO

Special purpose acquisition company Williams Rowland Acquisition Corp. (NYSE: WRACU) went public on the New...

Tuesday, July 27, 2021, 12:21:00 PM

Investment Firm-Backed SPAC Sound Point Acquisition I Prices Upsized US$225 Million IPO

Special purpose acquisition company Sound Point Acquisition Corp I (Nasdaq: SPCMU) started trading publicly on...

Wednesday, March 2, 2022, 02:23:00 PM

SPAC Chavant Capital Acquisition Seeks To Raise US$80 Million In IPO

Special purpose acquisition company Chavant Capital Acquisition Corp. went public on Nasdaq Capital Market today....

Tuesday, July 20, 2021, 11:38:00 AM

Cannabis-Focused Finance Company Altmore Capital Files For Nasdaq IPO

Specialty finance company Altmore BDC, Inc., also known as Altmore Capital, is looking to go...

Wednesday, February 9, 2022, 02:27:00 PM

Biotech Firm Blue Water Vaccines Prices US$20 Million IPO

Biopharmaceutical company Blue Water Vaccines, Inc. (Nasdaq: BWV) began trading on the Nasdaq Capital Market...

Monday, February 21, 2022, 04:33:00 PM